Advertisement
top banner image  

topleft corner image     top right corner image
 
take action
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

jacc imaging image
bullet
bullet
bullet
bullet

acc links
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

JACC Homepage JACC Interventions Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?

     top nav image

     

J Am Coll Cardiol Img, 2009; 2:1198-1208, doi:10.1016/j.jcmg.2009.06.013
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Mekkaoui, C.
Right arrow Articles by Sinusas, A. J.
PubMed
Right arrow Articles by Mekkaoui, C.
Right arrow Articles by Sinusas, A. J.
Related Collections
Right arrowRelated Article

Effects of Adenosine and a Selective A2A Adenosine Receptor Agonist on Hemodynamic and Thallium-201 and Technetium-99m–SestaMIBI Biodistribution and Kinetics

Choukri Mekkaoui, PhD*, Farid Jadbabaie, MD*, Donald P. Dione, BS*, David F. Meoli, MD, PhD*, Kailasnath Purushothaman, PhD{dagger}, Luiz Belardinelli, MD{ddagger}, Albert J. Sinusas, MD*,{dagger},*

* Division of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut
{dagger} Department of Diagnostic Radiology, Yale University School of Medicine, New Haven, Connecticut
{ddagger} CV Therapeutics, Inc., Palo Alto, California

* Reprint requests and correspondence: Dr. Albert J. Sinusas, Yale University School of Medicine, Nuclear Cardiology, 3FMP, P.O. Box 208017, New Haven, Connecticut 06520-8017 (Email: albert.sinusas{at}yale.edu).

Objectives: The purpose of this study was to compare a selective A2A adenosine receptor agonist (regadenoson) with adenosine in clinically relevant canine models with regard to effects on hemodynamics and thallium-201 (201Tl) and technetium-99m (99mTc)-sestaMIBI biodistribution and kinetics.

Background: The clinical application of vasodilator stress for perfusion imaging requires consideration of the effects of these vasodilating agents on systemic hemodynamics, coronary flow, and radiotracer uptake and clearance kinetics.

Methods: Sequential imaging and arterial blood sampling was performed on control, anesthetized closed-chest canines (n = 7) to evaluate radiotracer biodistribution and kinetics after either a bolus administration of regadenoson (2.5 µg/kg) or 4.5-min infusion of adenosine (280 µg/kg). The effects of regadenoson on coronary flow and myocardial radiotracer uptake were then evaluated in an open-chest canine model of a critical stenosis (n = 7). Results from ex vivo single-photon emission computed tomography were compared with tissue well-counting.

Results: The use of regadenoson compared favorably with adenosine in regard to the duration and magnitude of the hemodynamic effects and the effect on 201Tl and 99mTc-sestaMIBI biodistribution and kinetics. The arterial blood clearance half-time was significantly faster for 99mTc-sestaMIBI (regadenoson: 1.4 ± 0.03 min; adenosine: 1.5 ± 0.08 min) than for 201Tl (regadenoson: 2.5 ± 0.16 min, p < 0.01; adenosine: 2.7 ± 0.04 min, p < 0.01) for both vasodilator stressors. The relative microsphere flow deficit (0.34 ± 0.02%) during regadenoson stress was significantly greater than the relative perfusion defect with 99mTc-sestaMIBI (0.69 ± 0.03%, p < 0.001) or 201Tl (0.53 ± 0.02%, p < 0.001), although 201Tl tracked the flow deficit within the ischemic region better than 99mTc-sestaMIBI. The perfusion defect score was larger with 201Tl (22 ± 2.8% left ventricular) than with 99mTc-sestaMIBI (17 ± 1.7% left ventricular, p < 0.05) on ex vivo single-photon emission computed tomography images.

Conclusions: The bolus administration of regadenoson produced a hyperemic response comparable to a standard infusion of adenosine. The biodistribution and clearance of both 201Tl and 99mTc-sestaMIBI during regadenoson were similar to adenosine vasodilation. Ex vivo perfusion images under the most ideal conditions permitted detection of a critical stenosis, although 201Tl offered significant advantages over 99mTc-sestaMIBI for perfusion imaging during regadenoson vasodilator stress.

Key Words: regadenoson • myocardial perfusion imaging • adenosine • biodistribution • tracer kinetics

Abbreviations and Acronyms
  AoP = aortic pressure
  DPI = dynamic planar Imaging
  HR = heart rate
  IS = ischemic
  LAD = left anterior descending artery
  LCX = left circumflex artery
  LV = left ventricular
  MBF = myocardial blood flow
  MPI = myocardial perfusion imaging
  NI = nonischemic
  %ID = percent injected dose
  SPECT = single-photon emission computed tomography
  99mTc = technetium-99m
  201Tl = thallium-201


Related Article

Connectivity of Radiotracers to Vasodilators: Is Thallium the Missing Link?
Vasken Dilsizian
J. Am. Coll. Cardiol. Img. 2009 2: 1209-1212. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J Am Coll Cardiol ImgHome page
V. Dilsizian
Connectivity of Radiotracers to Vasodilators: Is Thallium the Missing Link?
J. Am. Coll. Cardiol. Img., October 1, 2009; 2(10): 1209 - 1212.
[Full Text] [PDF]



Advertisement
 
   
 
home link current link search link archive link topics link cardiology careers link